Stormorken syndrome caused by <em>STIM1</em> mutation: A case report and literature review Corrigendum in /10.3892/mi.2023.122

Sun,Wenqiang; Hu,Jinhui; Li,Mengzhao; Huo,Jie; Zhu,Xueping

doi:10.3892/mi.2022.54

Stormorken syndrome caused by <em>STIM1</em> mutation: A case report and literature review

Corrigendum in: /10.3892/mi.2023.122

Authors:
- Wenqiang Sun
- Jinhui Hu
- Mengzhao Li
- Jie Huo
- Xueping Zhu
View Affiliations

Affiliations: Department of Neonatology, Children's Hospital of Soochow University, Suzhou, Jiangsu 215025, P.R. China
Published online on: September 19, 2022 https://doi.org/10.3892/mi.2022.54
Article Number: 29
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present case study was to identify the genetic cause of a patient with a clinical presentation of tubular aggregate myopathy (TAM)/Stormorken syndrome (STRMK) and review the published clinical data of patients with TAM/STRMK. A child with thrombocytopenia and hyperCKemia at the Children's Hospital of Soochow University were recruited in the study. Peripheral blood samples of the infant and her parents were collected, and then whole‑exome sequencing was performed. Detection of the stromal interaction molecule 1 (STIM1) level of the child was performed using western blot analysis. In addition, a literature review was performed based on a thorough retrieval of published literature from the PubMed database, as well as domestic databases. In the present study, the c.326A>G mutation in a STIM1 allele (p.H109R) was identified only in the child, as opposed to the unaffected parents. The level of STIM1 was not decreased in the child. Among the mutation sites identified in previous studies, there were 46 cases across 30 families of STIM1 EF‑hand mutations, 21 cases across 14 families of STIM1 CC1 mutations and 20 cases across 8 families of calcium release‑activated calcium channel protein 1 mutations, in which 7 parents had the same mutation site as the patient described herein. On the whole, it is demonstrated that TAM/STRMK is an extremely rare disease with autosomal dominant inheritance. Patients often have multisystemic signs. Gene detection at an early stage is helpful for diagnosis. Long‑term exercise training may also have a certain curative effect.

View Figures

View References

1	Böhm J, Chevessier F, Koch C, Peche GA, Mora M, Morandi L, Pasanisi B, Moroni I, Tasca G, Fattori F, et al: Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1. J Med Genet. 51:824–833. 2014.PubMed/NCBI View Article : Google Scholar
2	Lacruz RS and Feske S: Diseases caused by mutations in ORAI1 and STIM1. Ann N Y Acad Sci. 1356:45–79. 2015.PubMed/NCBI View Article : Google Scholar
3	Bohm J and Laporte J: Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome. Cell Calcium. 76:1–9. 2018.PubMed/NCBI View Article : Google Scholar
4	Misceo D, Holmgren A, Louch WE, Holme PA, Mizobuchi M, Morales RJ, De Paula AM, Stray-Pedersen A, Lyle R, Dalhus B, et al: A dominant STIM1 mutation causes Stormorken syndrome. Hum Mutat. 35:556–564. 2014.PubMed/NCBI View Article : Google Scholar
5	Dynes JL, Yeromin AV and Cahalan MD: Cell-wide mapping of Orai1 channel activity reveals functional heterogeneity in STIM1-Orai1 puncta. J Gen Physiol. 152(e201812239)2020.PubMed/NCBI View Article : Google Scholar
6	Lee KW, Maeng JS, Choi JY, Lee YR, Hwang CY, Park SS, Park HK, Chung BH, Lee SG, Kim YS, et al: Role of Junctin protein interactions in cellular dynamics of calsequestrin polymer upon calcium perturbation. J Biol Chem. 287:1679–1687. 2012.PubMed/NCBI View Article : Google Scholar
7	Peche GA, Spiegelhalter C, Silva-Rojas R, Laporte J and Böhm J: Functional analyses of STIM1 mutations reveal a common pathomechanism for tubular aggregate myopathy and Stormorken syndrome. Neuropathology. 40:559–569. 2020.PubMed/NCBI View Article : Google Scholar
8	Böhm J, Bulla M, Urquhart JE, Malfatti E, Williams SG, O'Sullivan J, Szlauer A, Koch C, Baranello G, Mora M, et al: ORAI1 mutations with distinct channel gating defects in tubular aggregate myopathy. Hum Mutat. 38:426–438. 2017.PubMed/NCBI View Article : Google Scholar
9	Bohm J, Chevessier F, Maues De Paula A, Koch C, Attarian S, Feger C, Hantaï D, Laforêt P, Ghorab K, Vallat JM, et al: Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am J Hum Genet. 92:271–278. 2013.PubMed/NCBI View Article : Google Scholar
10	Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al: Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
11	Morin G, Biancalana V, Echaniz-Laguna A, Noury JB, Lornage X, Moggio M, Ripolone M, Violano R, Marcorelles P, Maréchal D, et al: Tubular aggregate myopathy and Stormorken syndrome: Mutation spectrum and genotype/phenotype correlation. Hum Mutat. 41:17–37. 2020.PubMed/NCBI View Article : Google Scholar
12	Walter MC, Rossius M, Zitzelsberger M, Vorgerd M, Müller-Felber W, Ertl-Wagner B, Zhang Y, Brinkmeier H, Senderek J and Schoser B: 50 years to diagnosis: Autosomal dominant tubular aggregate myopathy caused by a novel STIM1 mutation. Neuromuscul Disord. 25:577–584. 2015.PubMed/NCBI View Article : Google Scholar
13	Harris E, Burki U, Marini-Bettolo C, Neri M, Scotton C, Hudson J, Bertoli M, Evangelista T, Vroling B, Polvikoski T, et al: Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains. Neuromuscul Disord. 27:861–872. 2017.PubMed/NCBI View Article : Google Scholar
14	Noury JB, Bohm J, Peche GA, Guyant-Marechal L, Bedat-Millet AL, Chiche L, Carlier RY, Malfatti E, Romero NB and Stojkovic T: . Tubular aggregate myopathy with features of Stormorken disease due to a new STIM1 mutation. Neuromuscul Disord. 27:78–82. 2017.PubMed/NCBI View Article : Google Scholar
15	Hedberg C, Niceta M, Fattori F, Lindvall B, Ciolfi A, D'Amico A, Tasca G, Petrini S, Tulinius M, Tartaglia M, et al: Childhood onset tubular aggregate myopathy associated with de novo STIM1 mutations. J Neurol. 261:870–876. 2014.PubMed/NCBI View Article : Google Scholar
16	Markello T, Chen D, Kwan JY, Horkayne-Szakaly I, Morrison A, Simakova O, Maric I, Lozier J, Cullinane AR, Kilo T, et al: York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1. Mol Genet Metab. 114:474–482. 2015.PubMed/NCBI View Article : Google Scholar
17	Shahrizaila N, Lowe J and Wills A: Familial myopathy with tubular aggregates associated with abnormal pupils. Neurology. 63:1111–1113. 2004.PubMed/NCBI View Article : Google Scholar
18	Nesin V, Wiley G, Kousi M, Ong EC, Lehmann T, Nicholl DJ, Suri M, Shahrizaila N, Katsanis N, Gaffney PM, et al: Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis. Proc Natl Acad Sci USA. 111:4197–4202. 2014.PubMed/NCBI View Article : Google Scholar
19	Morin G, Bruechle NO, Singh AR, Knopp C, Jedraszak G, Elbracht M, Brémond-Gignac D, Hartmann K, Sevestre H, Deutz P, et al: Gain-of-Function mutation in STIM1 (P.R304W) is associated with Stormorken syndrome. Hum Mutat. 35:1221–1232. 2014.PubMed/NCBI View Article : Google Scholar
20	Okuma H, Saito F, Mitsui J, Hara Y, Hatanaka Y, Ikeda M, Shimizu T, Matsumura K, Shimizu J, Tsuji S and Sonoo M: Tubular aggregate myopathy caused by a novel mutation in the cytoplasmic domain of STIM1. Neurol Genet. 2(e50)2016.PubMed/NCBI View Article : Google Scholar
21	Endo Y, Noguchi S, Hara Y, Hayashi YK, Motomura K, Miyatake S, Murakami N, Tanaka S, Yamashita S, Kizu R, et al: Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca²⁺ channels. Hum Mol Genet. 24:637–648. 2015.PubMed/NCBI View Article : Google Scholar
22	Li A, Kang X, Edelman F and Waclawik AJ: Stormorken syndrome: A rare cause of myopathy with tubular aggregates and dystrophic features. J Child Neurol. 34:321–324. 2019.PubMed/NCBI View Article : Google Scholar
23	Jiang LJ, Zhao X, Dou ZY, Su QX and Rong ZH: Stormorken syndrome caused by a novel STIM1 mutation: A case report. Front Neurol. 12(522513)2021.PubMed/NCBI View Article : Google Scholar
24	Ticci C, Cassandrini D, Rubegni A, Riva B, Vattemi G, Matà S, Ricci G, Baldacci J, Guglielmi V, Di Muzio A, et al: Expanding the clinical and genetic spectrum of pathogenic variants in STIM1. Muscle Nerve. 64:567–575. 2021.PubMed/NCBI View Article : Google Scholar
25	Schiaffino S and Reggiani C: Fiber types in mammalian skeletal muscles. Physiol Rev. 91:1447–1531. 2011.PubMed/NCBI View Article : Google Scholar
26	Nakamura L, Sandrock-Lang K, Speckmann C, Vraetz T, Bührlen M, Ehl S, Heemskerk JW and Zieger B: Platelet secretion defect in a patient with stromal interaction molecule 1 deficiency. Blood. 122:3696–3698. 2013.PubMed/NCBI View Article : Google Scholar
27	Boncompagni S, Pecorai C, Michelucci A, Pietrangelo L and Protasi F: Long-term exercise reduces formation of tubular aggregates and promotes maintenance of Ca²⁺ entry units in aged muscle. Front Physiol. 11(601057)2020.PubMed/NCBI View Article : Google Scholar
28	Protasi F, Pietrangelo L and Boncompagni S: Calcium entry units (CEUs): Perspectives in skeletal muscle function and disease. J Muscle Res Cell Motil. 42:233–249. 2021.PubMed/NCBI View Article : Google Scholar